GKB Ophthalmics Ltd (GKB) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by GKB Ophthalmics Ltd on NSE and BSE, with an AI summary of each filing.
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....
Intimation · 12 Nov 2026, 5:30 am
GKB Ophthalmics Board Meeting Scheduled for Nov'26 Results Approval GKB Ophthalmics Ltd. has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company equity shares by designated persons, which closed on 1st Oct'26, will reopen 48 hours after the submission of results to the stock exchange.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclosed herewith a copy of the Minutes of the proceedings of the ....
Annual General Meeting · 22 Sept 2026, 6:53 pm
The 44th Annual General Meeting of the Company was held on August 25, 2026 at 11:00 A.M. ,at the registered office of the Company at 16-A, Tivim Industrial Estate, Mapusa Goa-403526. Pursuant ....
Annual General Meeting · 26 Aug 2026, 8:00 pm
The 44th Annual General Meeting of the Company was held today i.e Tuesday , August 25th, 2026, at 11.00 A. M., at the Registered Office of the Company at 16- A, Tivim Industrial Estate, ....
Annual General Meeting · 25 Aug 2026, 6:20 pm
Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The above unaudited Financial Results and the Limited Review Reports ....
Financial Result · 13 Aug 2026, 12:05 am
The meeting of the Board of Directors of the Company was held on August 12, 2026 which considered and took on record inter alia the unaudited Standalone and Consolidated Financial Results ....
Outcome · 12 Aug 2026, 11:41 pm
Pursuant to Regulation 36(1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Company has sent a letter to those shareholders whose email addresses are ....
Annual Report · 31 Jul 2026, 9:55 pm
Pursuant to Regulation 34 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a copy of the Annual Report along with the Notice of ....
Others (Uncategorized) · 31 Jul 2026, 6:23 pm
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
Intimation · 12 Aug 2026, 5:30 am
GKB Ophthalmics Ltd. Board Meeting Set for Q1 FY27 Results GKB Ophthalmics Ltd. (BSE: 533212) has scheduled a Board of Directors meeting on 12 Aug'26 to consider and approve its unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. In connection with this, the trading window for designated persons, which closed on 01 Jul'26, will re-open 48 hours after the results are submitted to the stock exchange.
In continuation to intimation filed by the company on September 12, 2025 informing of the development in relation to the ongoing Litigation wherein an Award was passed by the Industrial ....
Others (Uncategorized) · 14 Jul 2026, 7:30 pm
GKB Ophthalmics Receives Notice of Demand for Rs. 8.82 Crore GKB Ophthalmics received a "Notice of Demand" on 13-Jul'26 for the recovery of Rs. 8,82,00,856/- regarding an ongoing labour litigation case. The demand, originating from an Order by the Labour Commissioner dated 04-Sep'25, requires payment within 10 days. The company intends to challenge this notice by filing a writ petition before the High Court of Bombay. This development stems from a prior Industrial Tribunal award from 25-May'21, which GKB is already contesting.
Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI ( Prohibition of Insider TRading ) Regulations, 2015 (PIT Regulation 2015) intimation be and is hereby given that ....
Others (Uncategorized) · 30 Jun 2026, 6:48 pm
GKB Ophthalmics: Promoter Group Member Acquires Shares via Market Purchase Promoter group entity Krishna Gopal Gupta & Sons (HUF) acquired 1,016 equity shares of GKB Ophthalmics for a total consideration of Rs. 64,801.77. The on-market transactions occurred between 08 Jun'26 and 17 Jun'26. This purchase increased their holding from 300,053 shares (5.95%) to 301,069 shares (5.97%). The transaction was disclosed on 30 Jun'26 as a voluntary good corporate governance measure, as it did not breach the prescribed insider trading threshold limits.
Enclosed please find the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. Kindly take the information on record.
Financial Result · 28 May 2026, 2:04 am
GKB Ophthalmics Reports Widened FY26 Consolidated Loss Amidst Higher Revenue GKB Ophthalmics' consolidated net loss widened to Rs. 103.26 lakhs for FY26 from Rs. 861.22 lakhs in FY25, despite a 37% YoY revenue increase to Rs. 15,130.83 lakhs. The Q4FY26 consolidated loss was Rs. 101.24 lakhs, an improvement from a Rs. 446.89 lakhs loss in Q4FY25. On a standalone basis, the FY26 net loss narrowed to Rs. 356.79 lakhs from Rs. 610.79 lakhs. The company reported a one-time exceptional expense of Rs. 178.99 lakhs related to new labour code liabilities in FY26.
The meeting of the Board of Directors of the Company was held on May 27, 2026 which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company ....
Outcome · 28 May 2026, 1:45 am
GKB Ophthalmics Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 2,979 (-4.0% YoY | -47.5% QoQ) ■ EBITDA: 311 (Loss to Profit YoY | +87.9% QoQ) ■ EBITDA Margin (%): 10.4 (Loss to Profit YoY | +753 bps QoQ) ■ PAT: 19.3 (Loss to Profit YoY | -56.3% QoQ) ■ EPS (INR): 0.38 (Loss to Profit YoY | -56.8% QoQ)
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that CRISIL Ratings Limited (" CRISIL Ratings") has migrated the ....
Others (Uncategorized) · 27 May 2026, 5:41 pm
GKB Ophthalmics Bank Facilities Affirmed 'Crisil D' on Weak Financials CRISIL Ratings has affirmed GKB Ophthalmics' rating at 'Crisil D' for its Rs. 15.1 Crore bank loan facilities, migrating from 'Crisil D Issuer Not Cooperating'. The rating reflects a modest scale of operations, persistent EBITDA losses for seven years, and weak debt protection metrics. For fiscal 2026, interest coverage and net cash accruals to adjusted debt ratios are expected to be negative at -1.2x to -1.3x and -0.01x respectively. Poor liquidity persists, with insufficient cash accruals to meet debt obligations of Rs. 30-35 Lakhs.
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....
Intimation · 27 May 2026, 5:30 am
GKB Ophthalmics Sets Board Meeting for Q4 & FY26 Results GKB Ophthalmics (BSE: 533212) will hold a Board of Directors meeting on 27 May'26 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31 Mar'26. The trading window for designated persons, closed since 01 Apr'26, will reopen 48 hours after the results are submitted to the stock exchange.
Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26,2018, issued by the securities and Exchange Board of India , we hereby confirm that GKB Ophthalmics Limited, is not ....
Others (Uncategorized) · 07 Apr 2026, 5:40 pm
GKB Ophthalmics Confirms Non-Applicability of Large Corporate Framework GKB Ophthalmics Ltd. (BSE: 533212) has formally notified the exchange on 07 Apr'26 that it does not meet the criteria of a "Large Corporate" as defined by SEBI's circular dated 26 Nov'18. Consequently, the fund-raising framework and related compliance requirements outlined in the circular are not applicable to the company. This clarification confirms its status as a smaller entity, exempting it from specific mandatory bond issuance regulations intended for larger firms.
Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeover ) Regulation 2011 for the ....
Others (Uncategorized) · 02 Apr 2026, 9:11 pm
GKB Ophthalmics: Promoter Group Confirms No Share Encumbrance for FY26 GKB Ophthalmics Ltd. disclosed that its Promoter and Promoter Group have not created any encumbrance on their shares, directly or indirectly, for the financial year ended 31 Mar'26. The confirmation was submitted by promoter Mr. Krishna Gopal Gupta on behalf of the promoter group under Regulation 31(4) of the SEBI (SAST) Regulations, 2011. This indicates no pledging of promoter holdings during the specified period. The filing was made with the BSE on 02 Apr'26.
A Seperate meeting of Independent Directors'' Meeting of the Company for the year 2025-26, was held, pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosures Requirements) ....
Others (Uncategorized) · 18 Mar 2026, 11:28 pm
GKB Ophthalmics: Outcome of Independent Directors' Meeting GKB Ophthalmics' Independent Directors held a meeting on 18 Mar'26 to conduct their annual performance review for FY26. Key agenda items included reviewing the performance of Non-Independent Directors, the Board as a whole, and the Chairperson. The directors also assessed the quality, quantity, and timeliness of information flow between management and the Board. This is a routine corporate governance meeting held pursuant to SEBI regulations and the Companies Act, 2013, with no immediate financial or strategic announcements disclosed.
Notice is hereby given that pursuant to Regulation 25 (3 & 4) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, and Schedule IV, clause VII of the Companies Act, ....
Others (Uncategorized) · 09 Mar 2026, 10:30 pm
GKB Ophthalmics Schedules Independent Directors' Meeting for March 2026 GKB Ophthalmics Ltd. (BSE: 533212) has scheduled a meeting of its Independent Directors for Wed, 18 Mar'26. The agenda includes reviewing the performance of Non-Independent Directors, the Board as a whole, and the Chairman. Directors will also assess the quality, quantity, and timeliness of information flow between management and the Board to ensure effective performance of their duties. The meeting complies with SEBI (LODR) Regulations, 2015 and the Companies Act, 2013.
Enclosed please find Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended December 31, 2025
Financial Result · 13 Feb 2026, 2:59 am
GKB Ophthalmics Reports Q3FY26 Profit Reversal Driven by Lower Operating Costs GKB Ophthalmics reported a consolidated net profit of Rs. 44.30 lakhs for Q3FY26, a significant turnaround from a Rs. 203.00 lakh loss in Q3FY25 and a Rs. 160.03 lakh profit last quarter. Revenue from operations surged 120% YoY to Rs. 5,679.35 lakhs. The standalone business also swung to a profit of Rs. 98.08 lakhs from a loss of Rs. 16.74 lakhs YoY. This performance was driven by a substantial decrease in standalone total expenses to Rs. 699.16 lakhs, down 26.8% YoY.
The Meeting of the Board of Directors of the Company was held on February 12, 2026, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the ....
Outcome · 13 Feb 2026, 2:36 am
GKB Ophthalmics Limited - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 5679 (+120.1% YoY | +88.2% QoQ) ■ EBITDA: 136 (Loss to Profit YoY | -55.4% QoQ) ■ EBITDA Margin (%): 2.4 (Loss to Profit YoY | -770 bps QoQ) ■ PAT: 44.3 (Loss to Profit YoY | -72.3% QoQ) ■ EPS (INR): 0.88 (Loss to Profit YoY | -72.2% QoQ)
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited Standalone and ....
Intimation · 12 Feb 2026, 5:30 am
GKB Ophthalmics Board Meeting Set for Q3FY26 Results GKB Ophthalmics (BSE: 533212) will hold a Board of Directors meeting on 12 Feb'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 Dec'25. The trading window for designated persons, closed from 01 Jan'26, will re-open 48 hours after the results are submitted to the stock exchange.
We would like to inform you that the Statutory Auditor''s of the Company, MSKA & Associates, Chartered Accountants have intimated the Company that the Firm has converted itself into a Limited ....
Change in Auditor · 20 Jan 2026, 10:48 pm
GKB Ophthalmics' Statutory Auditor Converts to Limited Liability Partnership GKB Ophthalmics Ltd. (BSE: 533212) announced on Jan 20, '26, that its Statutory Auditors, MSKA & Associates, Chartered Accountants, have converted into a Limited Liability Partnership (LLP). The firm will now operate as MSKA & Associates LLP. This change in legal structure does not affect their role, and they will continue to serve as the company's Statutory Auditors for the remainder of their appointed tenure. The transition is purely a corporate restructuring of the audit firm with no change in personnel or responsibilities for GKB's audit.
Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI(Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations, 2015), intimation be and is hereby given ....
Others (Uncategorized) · 30 Dec 2025, 8:42 pm
GKB Ophthalmics: Promoter Group Entity Acquires Additional Shares Promoter group entity, Krishna Gopal Gupta & Sons (HUF), purchased 3,607 equity shares of GKB Ophthalmics for an aggregate value of ₹2,14,003.07. The on-market transactions occurred between 20-Nov'25 and 10-Dec'25. This series of purchases increased the entity's holding from 296,446 shares (5.88%) to 300,053 shares (5.95%). The company noted this disclosure was made as a good corporate governance measure as the trades did not exceed the prescribed regulatory threshold limits requiring mandatory disclosure.
Pursuant to Regulation 30 , of SEBI(LODR) Regulation, 2015, we wish to inform you that the members of GSV Ophthalmics Private Limited of Material Subsidiary of the company at their Extraordinary ....
Extra Ordinary General Meeting · 21 Nov 2025, 11:12 pm